Article | July 5, 2023

Optimizing Clinical Trials Through Ethical Technology For Non-Technical Users

Source: DIA

By Mathew E. Rose, SAAVHA Inc., IEEE Standards Association

AI-Artificial Intelligence GettyImages-1244482898

The integration of technology, such as sensors, telehealth, remote monitoring, and AI, is becoming increasingly significant in the design and execution of clinical trials, which are pivotal for healthcare advancements. However, it is important to consider how the adoption of these emerging technologies aligns with clinical research ethics and regulatory frameworks.

Since 2000, the National Institutes of Health (NIH) has developed seven ethical research guiding principles. These could be considered when assessing new technology for adoption, along with regulatory requirements like the FDA’s 21 CFR Part 11 (US) and Europe’s Annex 11, as well as unique regional requirements of the participant populations.

Learn more about ethical research practices and how the approved uses of AI technology in the life sciences industry must be developed within a regulatory framework to ensure its meaningful and standardized utility.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader